FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4304014798> ?p ?o ?g. }

• W4304014798 endingPage "55" @default.
• W4304014798 startingPage "46" @default.
• W4304014798 abstract "Macrophage migration inhibitory factor (MIF1) is a pleiotropic cytokine involved in inflammation and cancer. Genetic knockout of Mif1 in the validated N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) model of bladder cancer (BCa) resulted in stage arrest at non-muscle-invasive disease in prior studies. Small-molecule inhibition of MIF1 reduced cancer-associated outcomes, but it did not fully recapitulate genetic models. D-dopachrome tautomerase (gene symbol DDT), commonly referred to as MIF2, is a functional homolog of MIF1, and both MIF1 and MIF2 can bind the cell surface receptor CD74 on multiple cell types to initiate a signaling cascade. It has been proposed that this interaction mediates part of the protumorigenic effects of MIF1 and MIF2 and may explain the discordance in prior studies. We hypothesized that MIF2 functions redundantly with MIF1 in BCa development and progression. The Cancer Genome Atlas (TCGA) analysis indicated MIF and DDT expression were increased in BCa patients compared to control. 4-Iodopyridine (4-IPP), a combined MIF1/MIF2 inhibitor, was more efficacious than ISO-1, a MIF1-only inhibitor, in preventing cellular proliferation in BCa cell lines. To evaluate these findings in vivo, wild-type (WT) and Mif1-/- animals were exposed to 0.05% BBN in drinking water for 16 weeks to initiate tumorigenesis and then evaluated over the subsequent 4 weeks for tumor formation and progression in the presence or absence of 4-IPP. 4-IPP reduced bladder weights in WT animals and bladder weights/tumor stage in Mif1-/- animals. To determine whether MIF1/MIF2 functioned through CD74 in BCa, WT or Cd74-/- animals were used in the same BBN model. Although these animals were partially protected against BBN-induced BCa, 4-IPP did not enhance this effect. In conclusion, our data suggest that MIF2 mechanistically functions in a similar protumorigenic manner to MIF1, and this is at least partially through CD74. Dual inhibition of MIF homologs is more efficacious at reducing tumor burden in this model of BCa. © 2022 The Pathological Society of Great Britain and Ireland." @default.
• W4304014798 created "2022-10-10" @default.
• W4304014798 creator A5006831611 @default.
• W4304014798 creator A5012025683 @default.
• W4304014798 creator A5023214008 @default.
• W4304014798 creator A5029020333 @default.
• W4304014798 creator A5036378302 @default.
• W4304014798 creator A5043335943 @default.
• W4304014798 creator A5051762439 @default.
• W4304014798 creator A5061594984 @default.
• W4304014798 creator A5075838363 @default.
• W4304014798 date "2022-11-09" @default.
• W4304014798 modified "2023-10-18" @default.
• W4304014798 title "Role of <scp>MIF1</scp> / <scp>MIF2</scp> / <scp>CD74</scp> interactions in bladder cancer" @default.
• W4304014798 cites W2029174607 @default.
• W4304014798 cites W2064484362 @default.
• W4304014798 cites W2076093607 @default.
• W4304014798 cites W2083995543 @default.
• W4304014798 cites W2102590613 @default.
• W4304014798 cites W2103004412 @default.
• W4304014798 cites W2115424440 @default.
• W4304014798 cites W2115681156 @default.
• W4304014798 cites W2128754158 @default.
• W4304014798 cites W2131581428 @default.
• W4304014798 cites W2158525095 @default.
• W4304014798 cites W2161048718 @default.
• W4304014798 cites W2162068180 @default.
• W4304014798 cites W2173221039 @default.
• W4304014798 cites W2181078066 @default.
• W4304014798 cites W2502965415 @default.
• W4304014798 cites W2529744299 @default.
• W4304014798 cites W2531373072 @default.
• W4304014798 cites W2736730167 @default.
• W4304014798 cites W2791390184 @default.
• W4304014798 cites W2800769338 @default.
• W4304014798 cites W2808061953 @default.
• W4304014798 cites W2912966598 @default.
• W4304014798 cites W2922956741 @default.
• W4304014798 cites W2951252030 @default.
• W4304014798 cites W2978363899 @default.
• W4304014798 cites W3128394443 @default.
• W4304014798 cites W3160480051 @default.
• W4304014798 cites W4206122135 @default.
• W4304014798 cites W4211115520 @default.
• W4304014798 cites W4225626393 @default.
• W4304014798 doi "https://doi.org/10.1002/path.6018" @default.
• W4304014798 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36214539" @default.
• W4304014798 hasPublicationYear "2022" @default.
• W4304014798 type Work @default.
• W4304014798 citedByCount "0" @default.
• W4304014798 crossrefType "journal-article" @default.
• W4304014798 hasAuthorship W4304014798A5006831611 @default.
• W4304014798 hasAuthorship W4304014798A5012025683 @default.
• W4304014798 hasAuthorship W4304014798A5023214008 @default.
• W4304014798 hasAuthorship W4304014798A5029020333 @default.
• W4304014798 hasAuthorship W4304014798A5036378302 @default.
• W4304014798 hasAuthorship W4304014798A5043335943 @default.
• W4304014798 hasAuthorship W4304014798A5051762439 @default.
• W4304014798 hasAuthorship W4304014798A5061594984 @default.
• W4304014798 hasAuthorship W4304014798A5075838363 @default.
• W4304014798 hasBestOaLocation W43040147982 @default.
• W4304014798 hasConcept C104177226 @default.
• W4304014798 hasConcept C119997001 @default.
• W4304014798 hasConcept C121608353 @default.
• W4304014798 hasConcept C170627219 @default.
• W4304014798 hasConcept C185592680 @default.
• W4304014798 hasConcept C203014093 @default.
• W4304014798 hasConcept C207936829 @default.
• W4304014798 hasConcept C2776914184 @default.
• W4304014798 hasConcept C2778690821 @default.
• W4304014798 hasConcept C2779013556 @default.
• W4304014798 hasConcept C2779256057 @default.
• W4304014798 hasConcept C2780352672 @default.
• W4304014798 hasConcept C502942594 @default.
• W4304014798 hasConcept C54355233 @default.
• W4304014798 hasConcept C555283112 @default.
• W4304014798 hasConcept C86803240 @default.
• W4304014798 hasConcept C8891405 @default.
• W4304014798 hasConceptScore W4304014798C104177226 @default.
• W4304014798 hasConceptScore W4304014798C119997001 @default.
• W4304014798 hasConceptScore W4304014798C121608353 @default.
• W4304014798 hasConceptScore W4304014798C170627219 @default.
• W4304014798 hasConceptScore W4304014798C185592680 @default.
• W4304014798 hasConceptScore W4304014798C203014093 @default.
• W4304014798 hasConceptScore W4304014798C207936829 @default.
• W4304014798 hasConceptScore W4304014798C2776914184 @default.
• W4304014798 hasConceptScore W4304014798C2778690821 @default.
• W4304014798 hasConceptScore W4304014798C2779013556 @default.
• W4304014798 hasConceptScore W4304014798C2779256057 @default.
• W4304014798 hasConceptScore W4304014798C2780352672 @default.
• W4304014798 hasConceptScore W4304014798C502942594 @default.
• W4304014798 hasConceptScore W4304014798C54355233 @default.
• W4304014798 hasConceptScore W4304014798C555283112 @default.
• W4304014798 hasConceptScore W4304014798C86803240 @default.
• W4304014798 hasConceptScore W4304014798C8891405 @default.
• W4304014798 hasFunder F4320315768 @default.
• W4304014798 hasFunder F4320321723 @default.
• W4304014798 hasFunder F4320337351 @default.

• next